| Patient | Billie Holiday |
|---|---|
| Date of birth | 1915-04-07 |
| Identifiers | MRN HR-ML010-SYN-TD; SSN (made up) 000-10-4472 |
| Document date | 1948-04-20 |
| Author | Constance Mayfield, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Severe opioid use disorder and moderate alcohol use disorder in a 33-year-old singer, five weeks after release from about ten months in custody, when her tolerance is low and her overdose risk high. Buprenorphine with naloxone was started today. Please confirm the medication plan and dose, advise on a medicine for her drinking that is safe with buprenorphine, and help set the monitoring and recovery plan. [S]
Urgency: Within one week, on the same day as her one-week primary care visit. [S]
Questions for the consultant:
Heroin use since her twenties, becoming severe in the last few years; she has sought treatment before. No opioid use since release and no withdrawal today; no medication for opioid use disorder was offered in custody. Drinking four or five drinks on most performance nights since release (AUDIT-C 8; PEth 312 ng/mL); no history of withdrawal seizures or delirium. DAST-10 7. PHQ-9 9, item 9 scored 0; structured safety assessment shows no suicidal thoughts. Urine pregnancy test negative. Today: buprenorphine with naloxone, 4 mg today and then 8 mg daily; naloxone nasal spray; thiamine; Tdap, PCV20, and first doses of hepatitis A and B vaccines. Blood tests drawn today: AST 52, ALT 38, GGT 84 U/L, albumin 4.0 g/dL, bilirubin 0.7 mg/dL, MCV 101 fL, platelets 236, creatinine 0.72 mg/dL; hepatitis C antibody, hepatitis B triple panel, and HIV test sent. She has been singled out by law enforcement many times and is wary of clinics; she asks that she decide what is shared and with whom [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
3 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Buprenorphine 8 mg and naloxone 2 mg sublingual film: half a film (4 mg) on day 1, then one film (8 mg) under the tongue daily | One film under the tongue daily after a 4 mg first dose | Sublingual route | 1948-04-20 to 1948-04-27 | completed | S |
| Naloxone 4 mg nasal spray, one spray in one nostril for a suspected opioid overdose; may repeat every 2 to 3 minutes in alternating nostrils; call 911 | One spray (4 mg) in one nostril for suspected overdose; repeat every 2 to 3 minutes if there is no response | Nasal route | 1948-04-20 | active | S |
| Thiamine 100 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1948-04-20 to 1948-10-19 | completed | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Opioid use disorder (heroin), severe; in early remission in a controlled environment at intake, five weeks after release from custody; on buprenorphine; synthetic modern episode linked to her documented heroin use | active | confirmed | F11.20 | S — Synthetic modern coding of the documented heroin addiction; language is person-first, and the code does not change with a return to use. |
| Alcohol use disorder, moderate; synthetic modern episode linked to her documented heavier drinking after her mother's death | active | confirmed | F10.20 | S — Synthetic modern coding of the documented drinking; the liver disease reported in her last year is not coded, because it was documented long after the episode. |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| about 1943 | Heroin use from the early 1940s, becoming a severe addiction in the late 1940s; sought treatment for it at least once | D (CLM-0003, CLM-0005) |
| October 1945 | Heavier drinking and increased drug use after her mother's death | D (CLM-0002) |
| March 16, 1948 | Federal custody after a narcotics possession conviction, about ten months with enforced abstinence; released early | D (CLM-0004) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| mother | Died in 1945; cause not recorded in the cited source | D (CLM-0002) |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1948-04-20 | Body height | 165 | cm | S |
| 1948-04-20 | Body weight | 68 | kg | S |
| 1948-04-20 | Body mass index (BMI) [Ratio] | 25 | kg/m2 | S |
| 1948-04-20 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1948-04-20 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1948-04-20 | Heart rate | 84 | /min | S |
| 1948-04-20 | Respiratory rate | 16 | /min | S |
| 1948-04-20 | Body temperature | 36.8 | Cel | S |
| 1948-04-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1948-04-20 | Hemoglobin [Mass/volume] in Blood | 12.4 | g/dL | 11.6-15 g/dL | Normal | S |
| 1948-04-20 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 101 | fL | 80-100 fL | High | S |
| 1948-04-20 | Platelets [#/volume] in Blood by Automated count | 236 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1948-04-20 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 1948-04-20 | Potassium [Moles/volume] in Serum or Plasma | 4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1948-04-20 | Creatinine [Mass/volume] in Serum or Plasma | 0.72 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1948-04-20 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1943)/1.73 sq M | 113 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1948-04-20 | Glucose [Mass/volume] in Serum or Plasma | 88 | mg/dL | 70-99 mg/dL | Normal | S |
| 1948-04-20 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 52 | U/L | 10-40 U/L | High | S |
| 1948-04-20 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 38 | U/L | 7-56 U/L | Normal | S |
| 1948-04-20 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 84 | U/L | 5-40 U/L | High | S |
| 1948-04-20 | Albumin [Mass/volume] in Serum or Plasma | 4 | g/dL | 3.5-5 g/dL | Normal | S |
| 1948-04-20 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.7 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 1948-04-20 | Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay | 0.09 | {s_co_ratio} | Below 1.00 is nonreactive | Normal | S |
| 1948-04-20 | Hepatitis B virus surface Ab [Units/volume] in Serum | 3 | m[IU]/mL | >=10 m[IU]/mL | Low | S |
| 1948-04-20 | Phosphatidylethanol [Mass/volume] in Blood | 312 | ng/mL | Below 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinking | High | S |
| 1948-04-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 9 | {score} | S | ||
| 1948-04-20 | Total score [AUDIT-C] | 8 | {score} | S | ||
| 1948-04-20 | Total score [DAST-10] | 7 | {score} | S |